Autophagy-focused Casma Therapeutics debuts with $58.5 million from Third Rock
Thursday, July 5, 2018 - 18:20
in Health & Medicine
The biotech will first tackle lysosomal storage disorders
Updated by artificial intelligence Tue, 13 Jun 2023, 2:53:47 UTC Learn more
- Tell your friends
- Get science news via